Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-10-002115
Filing Date
2010-03-12
Accepted
2010-03-12 09:32:11
Documents
10
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2197212z10-k.htm 10-K 1031483
2 EXHIBIT 10.18 a2197212zex-10_18.htm EX-10.18 36360
3 EXHIBIT 10.25 a2197212zex-10_25.htm EX-10.25 18437
4 EXHIBIT 10.41 a2197212zex-10_41.htm EX-10.41 9740
5 EXHIBIT 21 a2197212zex-21.htm EX-21 4552
6 EXHIBIT 23.1 a2197212zex-23_1.htm EX-23.1 3012
7 EXHIBIT 31.1 a2197212zex-31_1.htm EX-31.1 7744
8 EXHIBIT 31.2 a2197212zex-31_2.htm EX-31.2 7759
9 EXHIBIT 32.1 a2197212zex-32_1.htm EX-32.1 4722
10 G485590.JPG g485590.jpg GRAPHIC 45336
  Complete submission text file 0001047469-10-002115.txt   1187831
Mailing Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142 617 491-9700
MOMENTA PHARMACEUTICALS INC (Filer) CIK: 0001235010 (see all company filings)

EIN.: 043561634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50797 | Film No.: 10675985
SIC: 2836 Biological Products, (No Diagnostic Substances)